NASDAQ:CYBX - Cyberonics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cyberonics logoCyberonics, Inc. is a medical device company. The Company is engaged in the design, development, sale and marketing of medical devices for epilepsy, depression and heart failure. Its seminal product, the VNS Therapy System, is an implantable device that provides neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment-resistant depression (TRD). The Company's VITARIA System is an implantable device that provides a form of neuromodulation therapy for the treatment of chronic heart failure (CHF). The VNS Therapy System and its VITARIA System include an implantable pulse generator to stimulate the vagus nerve; a lead that conducts current pulses from the pulse generator to the vagus nerve; a surgical instrument to assist with the implant procedure; equipment to enable the treating physician to set the pulse generator stimulation parameters for the patient; instruction manuals, and in the VNS Therapy System, magnets to suspend or induce stimulation manually.

Receive CYBX News and Ratings via Email

Sign-up to receive the latest news and ratings for CYBX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
SymbolNASDAQ:CYBX
CUSIP23251P10
Phone+1-281-2287200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins15.33%
Return on Equity17.49%
Return on Assets15.23%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00

Cyberonics (NASDAQ:CYBX) Frequently Asked Questions

What is Cyberonics' stock symbol?

Cyberonics trades on the NASDAQ under the ticker symbol "CYBX."

Has Cyberonics been receiving favorable news coverage?

News headlines about CYBX stock have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cyberonics earned a media and rumor sentiment score of 0.18 on Accern's scale. They also gave news coverage about the medical device company an impact score of 46.57 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future. View Recent Headlines for Cyberonics.

How do I buy shares of Cyberonics?

Shares of CYBX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact Cyberonics?

Cyberonics' mailing address is 100 Cyberonics Blvd, HOUSTON, TX 77058-2069, United States. The medical device company can be reached via phone at +1-281-2287200.


MarketBeat Community Rating for Cyberonics (NASDAQ CYBX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  194 (Vote Outperform)
Underperform Votes:  151 (Vote Underperform)
Total Votes:  345
MarketBeat's community ratings are surveys of what our community members think about Cyberonics and other stocks. Vote "Outperform" if you believe CYBX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYBX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/22/2018 by MarketBeat.com Staff

Featured Article: Index Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel